Citazione APA

Shitara, K., Hara, H., Yoshikawa, T., Fujitani, K., Nishina, T., Hosokawa, A., . . . Muro, K. (2019). Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: A subgroup analysis of the JACOB trial. Int J Clin Oncol.

Stile di citazione Chicago

Shitara, Kohei, Hiroki Hara, Takaki Yoshikawa, Kazumasa Fujitani, Tomohiro Nishina, Ayumu Hosokawa, Takashi Asakawa, Satoe Kawakami, e Kei Muro. "Pertuzumab Plus Trastuzumab and Chemotherapy for Japanese Patients With HER2-positive Metastatic Gastric or Gastroesophageal Junction Cancer: A Subgroup Analysis of the JACOB Trial." Int J Clin Oncol 2019.

Citazione MLA

Shitara, Kohei, et al. "Pertuzumab Plus Trastuzumab and Chemotherapy for Japanese Patients With HER2-positive Metastatic Gastric or Gastroesophageal Junction Cancer: A Subgroup Analysis of the JACOB Trial." Int J Clin Oncol 2019.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.